Search
for
Sort by
Research 751–780 of 1000+
- Transcriptomic analysis of regulatory mechanisms in the telogen-anagen transition of ovine hair follicles
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Optimization and Transfollicular Delivery of Finasteride Loaded PLGA Nanoparticles Laden Carbopol Gel for Treatment of Hair Growth Stimulation
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Research Progress in Chronic Autoimmune Urticaria
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Comparison of Efficacy of Oral Tofacitinib Versus Oral Minoxidil in Patients with Alopecia Areata
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Targeted immunotherapy for hair regrowth and regeneration
- Therapeutic Options to Refractory Alopecia Areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Ingestion of a dietary supplement resulting in selenium toxicity
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Hair and scalp‐related disorders are a trending topic in dermatology, with a significant increase in number of consultations in the last decade
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches